Product NDC: | 0228-2753 |
Proprietary Name: | Glyburide and Metformin Hydrochloride |
Non Proprietary Name: | Glyburide and Metformin Hydrochloride |
Active Ingredient(s): | 5; 500 mg/1; mg/1 & nbsp; Glyburide and Metformin Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0228-2753 |
Labeler Name: | Actavis Elizabeth LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076716 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050628 |
Package NDC: | 0228-2753-50 |
Package Description: | 500 TABLET in 1 BOTTLE (0228-2753-50) |
NDC Code | 0228-2753-50 |
Proprietary Name | Glyburide and Metformin Hydrochloride |
Package Description | 500 TABLET in 1 BOTTLE (0228-2753-50) |
Product NDC | 0228-2753 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Glyburide and Metformin Hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20050628 |
Marketing Category Name | ANDA |
Labeler Name | Actavis Elizabeth LLC |
Substance Name | GLYBURIDE; METFORMIN HYDROCHLORIDE |
Strength Number | 5; 500 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |